A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Behavioral Predictors Of Substance-Use Initiation In Adolescents With And Without ADHD
2006
Pediatric Neurology Briefs
Preserved Fulltext
COMMENT. At a mean daily dose of 24 mg/day, d-MPH-ER was significantly superior to placebo in the treatment of ADHD. The mean dose of d-MPH-ER found effective is equivalent to a 50 mg/day dose of racemic methylphenidate.
doi:10.15844/pedneurbriefs-20-7-8
fatcat:ecak7fitwjh6fb6flkqp6pvmrm